These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32235474)
1. Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis. De Paepe B; Merckx C; Jarošová J; Cannizzaro M; De Bleecker JL Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235474 [TBL] [Abstract][Full Text] [Related]
2. Hypotonic activation of the myo-inositol transporter SLC5A3 in HEK293 cells probed by cell volumetry, confocal and super-resolution microscopy. Andronic J; Shirakashi R; Pickel SU; Westerling KM; Klein T; Holm T; Sauer M; Sukhorukov VL PLoS One; 2015; 10(3):e0119990. PubMed ID: 25756525 [TBL] [Abstract][Full Text] [Related]
3. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth. Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium. Chauvin TR; Griswold MD Biol Reprod; 2004 Mar; 70(3):744-51. PubMed ID: 14613899 [TBL] [Abstract][Full Text] [Related]
5. SLC5A3 is important for cervical cancer cell growth. Li L; Shen FR; Cheng Q; Sun J; Li H; Sun HT; Cai X; Chen M; Yang B; Wang L; Xu L Int J Biol Sci; 2023; 19(9):2787-2802. PubMed ID: 37324953 [TBL] [Abstract][Full Text] [Related]
6. Activation of osmolyte pathways in inflammatory myopathy and Duchenne muscular dystrophy points to osmoregulation as a contributing pathogenic mechanism. De Paepe B; Martin JJ; Herbelet S; Jimenez-Mallebrera C; Iglesias E; Jou C; Weis J; De Bleecker JL Lab Invest; 2016 Aug; 96(8):872-84. PubMed ID: 27322952 [TBL] [Abstract][Full Text] [Related]
7. The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Berry GT; Mallee JJ; Kwon HM; Rim JS; Mulla WR; Muenke M; Spinner NB Genomics; 1995 Jan; 25(2):507-13. PubMed ID: 7789985 [TBL] [Abstract][Full Text] [Related]
9. Increased trophoblast expression of NFAT5/TonEBP in pre-eclamptic placentas and hyperosmolar-treated BeWo cells. Lee GT; Price MD; Mejia CA; Galan HL; Arroyo JA Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():37-43. PubMed ID: 25461350 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis. Prayson RA; Cohen ML Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain. Buccafusca R; Venditti CP; Kenyon LC; Johanson RA; Van Bockstaele E; Ren J; Pagliardini S; Minarcik J; Golden JA; Coady MJ; Greer JJ; Berry GT Mol Genet Metab; 2008; 95(1-2):81-95. PubMed ID: 18675571 [TBL] [Abstract][Full Text] [Related]
12. Induction of Osmolyte Pathways in Skeletal Muscle Inflammation: Novel Biomarkers for Myositis. De Paepe B; Zschüntzsch J; Šokčević T; Weis J; Schmidt J; De Bleecker JL Front Neurol; 2018; 9():846. PubMed ID: 30364257 [TBL] [Abstract][Full Text] [Related]
14. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle. Zschüntzsch J; Voss J; Creus K; Sehmisch S; Raju R; Dalakas MC; Schmidt J Arthritis Rheum; 2012 Dec; 64(12):4094-103. PubMed ID: 22941914 [TBL] [Abstract][Full Text] [Related]
15. Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. Berry GT; Wu S; Buccafusca R; Ren J; Gonzales LW; Ballard PL; Golden JA; Stevens MJ; Greer JJ J Biol Chem; 2003 May; 278(20):18297-302. PubMed ID: 12582158 [TBL] [Abstract][Full Text] [Related]
16. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423 [TBL] [Abstract][Full Text] [Related]
17. The 21q22.1 STS marker, VN02 (EST00541 cDNA), is part of the 3' sequence of the human Na+/myo-inositol cotransporter (SLC5A3) gene. Berry GT; Mallee JJ; Blouin JL; Antonarakis SE Cytogenet Cell Genet; 1996; 73(1-2):77-8. PubMed ID: 8646889 [TBL] [Abstract][Full Text] [Related]
18. Protein aggregation in inclusion body myositis, a sporadic form among protein aggregate myopathies, and in myofibrillar myopathies--a comparative study. Bastian A; Goebel HH Rom J Intern Med; 2010; 48(4):377-84. PubMed ID: 21528768 [TBL] [Abstract][Full Text] [Related]
19. SMIT (Sodium-Myo-Inositol Transporter) 1 Regulates Arterial Contractility Through the Modulation of Vascular Kv7 Channels. Barrese V; Stott JB; Baldwin SN; Mondejar-Parreño G; Greenwood IA Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2468-2480. PubMed ID: 32787517 [TBL] [Abstract][Full Text] [Related]
20. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]